V8Y — Quantum Healthcare Income Statement
0.000.00%
- SG$12.59m
- SG$15.43m
- SG$13.06m
Annual income statement for Quantum Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.001 | 9.37 | 13.1 | 12.7 | 13.1 |
| Cost of Revenue | |||||
| Gross Profit | — | 4.35 | 5.76 | 5.66 | 5.93 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | — | 17.7 | 15.9 | 14.7 | 15.6 |
| Operating Profit | — | -8.33 | -2.79 | -2.06 | -2.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | — | -8.78 | -3.28 | -2.52 | -2.85 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | — | -8.9 | -3.38 | -2.56 | -2.91 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | — | -9.07 | -3.62 | -2.23 | -2.74 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | — | -9.07 | -3.62 | -2.23 | -2.74 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | — | -0.001 | -0 | -0 | -0 |